All Clinical Trials
Mater conducts clinical trials in a range of therapeutic areas including Cancer, Nerouology, Medicine, Orthopaedics Surgery and Acute Care, and Mothers' and Babies Health. Clinical trials are an essential component of helathcare. They provide the evidence to evaluate the safety and efficacy of new treantments and diagnositics, and provide alternative treatment options for patients with unmet needs.
Do you have Muscle-invasive Bladder Cancer?
The trial is testing a potential new treatment called disitamab vedotin for Muscle-invasive Bladder Cancer.
Healing and Disease-Modifying Effect of Guselkumab in Crohn’s Disease Patients
A disease modification drug for Temporal Lobe Epilepsy
A disease modification drug for Temporal Lobe Epilepsy
SNDX-6352-0506 - Axatilimab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Axatilimab is a “monoclonal antibody”, which is an antibody manufactured in a laboratory. It is designed to specifically block a protein believed to be involved in lung fibrosis. By blocking this protein, Axatilimab may slow or stop the progression of IPF.
Testing a new treatment for people with Crohn's Disease
A Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis (SWIFT)
A Phase 3 Study to Evaluate the Efficacy and Safety of Pegozafermin in Subjects with Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
The IPPaM Study - Does Light-Therapy Reduce Osteoarthritis Knee Pain and Aid Willingness to Exercise?
An Investigation of the effects of Photobiomodulation (PBM) therapy on Pain and functional Mobility in people with knee osteoarthritis not awaiting knee replacement surgery (a pilot study with wait-list control)
Do you have Locally-advanced or Metastatic Non-squamous NSCLC With High PD-L1 Expression?
UPlift
A post-marketing study of UPadacitinib evaluating speed of onset and durability of effectiveness for patients with moderate to severe Crohn’s disease for 3 years in the real-world